Stroke and molecular imaging: a focus on FDG-PET

Area of Science:

• Neuroscience
• Medical Imaging
• Neurology

Background:

• Stroke is a primary cause of global disability, dementia, and mortality.
• Established imaging modalities like MRI and CT are crucial but have limitations in exploring stroke's molecular underpinnings.
• Understanding stroke etiology and mechanisms requires advanced investigative tools.

Purpose of the Study:

• To review the role of positron emission tomography (PET) in stroke research.
• To highlight PET's contributions to understanding stroke pathophysiology.
• To explore the potential clinical applications of PET in stroke management.

Main Methods:

• Literature review of studies utilizing positron emission tomography in stroke research.
• Analysis of PET's capability in molecular imaging of neurological diseases, specifically stroke.
• Examination of existing and emerging clinical applications of PET for stroke.

Main Results:

• PET serves as a powerful molecular imaging tool for neurological disease research.
• PET imaging provides detailed insights into the complex pathophysiology of stroke.
• Evidence suggests significant potential for PET in clinical stroke diagnosis and monitoring.

Conclusions:

• Positron emission tomography is instrumental in advancing stroke research.
• PET imaging deepens the understanding of stroke mechanisms and effects.
• Further clinical integration of PET holds promise for improved stroke care.